The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Whilst I don't agree with everything dropinmonkey says below I agree with the non-core issue and it being a distraction, came completely out of the blue and for me showed that Dan's focus was not completely where it should have been.
Is there a chance that gold production has been unaffected but gold sales have? Will the buyers still be in a position to buy or are we likely to find we have a higher level of inventory at the end of Q1? With the price going up this could be a win win situation.
I think Dan has made some big errors but the last 12 months has kept his head down and got production to where it should be but NOW is the time to show that he does care about the shareholders, there are a few options he could take but like others I am not convinced he gives a flying f*ck about shareholders but hope he proves me wrong.
20% drop in approx 2 weeks, strange.